COMPARING REAL-WORLD OUTCOMES, MEASURED AS 12 AND 24-MONTH IBD-RELATED SURGERIES, BETWEEN INFLIXIMAB DOSE OPTIMIZED PATIENTS USING THERAPEUTIC DRUG MONITORING (TDM) VS AN UNOPTIMIZED CONTROL GROUP, IN A LARGE US COMMUNITY-BASED GASTROENTEROLOGY PRACTICES

被引：0

|

作者：

Shim, Andrew

Han, Patita

Young, Kendra

St Jacque, Samantha

Sabban, Amit

Eisdorfer, Robert

Rosenberg, Shahar

机构：

来源：

GASTROENTEROLOGY | 2024年 / 166卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

收藏

页码：S116 / S116

页数：1

相关论文

共 3 条

[1] COMPARING REAL-WORLD OUTCOMES, MEASURED AS 12 AND 24-MONTH IBD-RELATED SURGERIES, BETWEEN INFLIXIMAB DOSE OPTIMIZED PATIENTS USING THERAPEUTIC DRUG MONITORING (TDM) VS AN UNOPTIMIZED CONTROL GROUP, IN A LARGE US COMMUNITY-BASED GASTROENTEROLOGY PRACTICES
Shim, Andrew
Han, Patita
Young, Kendra
St Jacque, Samantha
Sabban, Amit
Eisdorfer, Robert
Rosenberg, Shahar
INFLAMMATORY BOWEL DISEASES, 2024, 30 : S83 - S84
[2] COMPARISON OF LONG-TERM OUTCOMES, MEASURED AS 36-MONTH REAL-WORLD IBD HOSPITALIZATIONS, SURGERIES, AND EXPENDITURES, BETWEEN INFLIXIMAB DOSE OPTIMIZED USING THERAPEUTIC DRUG MONITORING (TDM) VS NO TDM CONTROL IN A US COMMUNITY GASTROENTEROLOGY PRACTICE
Shim, Andrew
Han, Patricia Aragon
Young, Kendra
Sabban, Amit
Eisdorfer, Robert M.
Rosenberg, Shahar
GASTROENTEROLOGY, 2024, 166 (05) : S819 - S819
[3] THERAPEUTIC DRUG MONITORING (TDM) OF INFLIXIMAB IS ASSOCIATED WITH LOWER BIOLOGIC SWITCH & EXPENDITURES COMPARED TO NO-TDM COHORT OF IBD PATIENTS BASED ON 12 TO 48-MONTH REAL-WORLD OUTCOMES FROM A US COMMUNITY GI PRACTICE
Shim, A.
Young, K.
Sabban, A.
Eisdorfer, R.
Rosenberg, S.
VALUE IN HEALTH, 2024, 27 (06) : S389 - S389